Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus remifentanil for hemodynamic response to extubation
IRCT20200825048515N74Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Mar 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine and remifentanil in elective surgery (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Blood pressure, Heart rate and 3 more. Started Mar 2024; status: completed.
02
Drugs
dexmedetomidineremifentanil
03
Conditions
elective surgery
Beyond the preview
Go deeper on IRCT20200825048515N74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200825048515N74.